These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 2495144)

  • 41. The effect of mitomycin C on superficial bladder cancer.
    Soloway MS; Murphy WM; DeFuria MD; Crooke S; Finebaum P
    J Urol; 1981 May; 125(5):646-8. PubMed ID: 6785454
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Local chemotherapy of bladder carcinoma with mitomycin (author's transl)].
    Flüchter SH; Harzmann R; Hlobil H; Erdmann W; Bichler KH
    Urologe A; 1982 Jan; 21(1):24-8. PubMed ID: 6805121
    [TBL] [Abstract][Full Text] [Related]  

  • 43. BCG-RIVM intravesical immunoprophylaxis for superficial bladder cancer.
    Debruyne FM; van der Meijden AP; Schreinemachers LM; Geboers AD; Franssen MP; van Leeuwen MJ; Steerenberg PA; de Jong WH; Ruitenberg EJ
    Prog Clin Biol Res; 1988; 269():511-24. PubMed ID: 3134662
    [No Abstract]   [Full Text] [Related]  

  • 44. Treatment of bladder carcinoma in situ with mitomycin C: long-term follow-up.
    Minervini R; Felipetto R; Viganò L; Cecchi M
    Int Urol Nephrol; 1994; 26(4):437-42. PubMed ID: 8002217
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intravesical bacillus Calmette-Guerin versus mitomycin C for Ta and T1 bladder cancer.
    Shelley MD; Court JB; Kynaston H; Wilt TJ; Coles B; Mason M
    Cochrane Database Syst Rev; 2003; (3):CD003231. PubMed ID: 12917955
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of intravesical mitomycin C on the recurrence of superficial (Ta-T1) bladder cancer. A Hungarian Multicenter Study.
    Kondás J; Kiss L; Határ A; Kiss A; Lukács T; Szeldeli P; Törzsök F; Bodrogi I
    Int Urol Nephrol; 1999; 31(4):451-6. PubMed ID: 10668939
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Blood and tissue levels of mitomycin C after intravesical instillation].
    Flüchter SH; Hlobil H; Harzmann R; Rothe KF; Bichler KH
    Urol Int; 1983; 38(6):321-8. PubMed ID: 6419427
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term efficacy of maintenance bacillus Calmette-Guérin versus maintenance mitomycin C instillation therapy in frequently recurrent TaT1 tumours without carcinoma in situ: a subgroup analysis of the prospective, randomised FinnBladder I study with a 20-year follow-up.
    Järvinen R; Kaasinen E; Sankila A; Rintala E;
    Eur Urol; 2009 Aug; 56(2):260-5. PubMed ID: 19395154
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cytostatic intravesical instillation in patients with superficial bladder carcinoma for the prevention of recurrent tumors.
    Huland H; Klöppel G; Otto U; Feddersen I; Brachmann W; Hubmann H; Kaufmann J; Knipper W; Lantzius-Beninga F
    Eur Urol; 1988; 14(3):202-6. PubMed ID: 3133216
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of different schedules of cytostatic intravesical instillations in patients with superficial bladder carcinoma: final evaluation of a prospective multicenter study with 419 patients.
    Huland H; Klöppel G; Feddersen I; Otto U; Brachmann W; Hubmann H; Kaufmann J; Knipper W; Lantzius-Beninga F; Huland E
    J Urol; 1990 Jul; 144(1):68-71; discussion 71-2. PubMed ID: 2113590
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intravesical thermo-chemotherapy based on conductive heat: a first pharmacokinetic study with mitomycin C in superficial transitional cell carcinoma patients.
    Milla P; Fiorito C; Soria F; Arpicco S; Cattel L; Gontero P
    Cancer Chemother Pharmacol; 2014 Mar; 73(3):503-9. PubMed ID: 24442034
    [TBL] [Abstract][Full Text] [Related]  

  • 52. BCG-RIVM versus BCG-Tice versus mitomycin-C in superficial bladder cancer. Rationale and design of the trial of the Southeast Co-operative Urological Group, The Netherlands.
    van der Meijden PM; Debruyne FM; Steerenberg PA; de Jong WH; Doesburg W
    Prog Clin Biol Res; 1989; 310():285-98. PubMed ID: 2505272
    [No Abstract]   [Full Text] [Related]  

  • 53. [Intravesical instillation of epirubicin hydrochloride in superficial bladder tumor--prophylactic and therapeutic instillation for carcinoma in situ].
    Shichiri Y; Kanba T; Yoshida S; Arai Y
    Hinyokika Kiyo; 1995 May; 41(5):359-64. PubMed ID: 7598036
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of local hyperthermia of the bladder on mitomycin C pharmacokinetics during intravesical chemotherapy for the treatment of superficial transitional cell carcinoma.
    Paroni R; Salonia A; Lev A; Da Pozzo LF; Cighetti G; Montorsi F; Rigatti P; Colombo R
    Br J Clin Pharmacol; 2001 Sep; 52(3):273-8. PubMed ID: 11560559
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Renal failure after intravesical mitomycin C.
    Farha AJ; Krauss DJ
    Urology; 1989 Oct; 34(4):216-7. PubMed ID: 2508290
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term observation after intravesical metaphylaxis with mitomycin C in patients with superficial bladder tumors.
    Maier U; Höbarth K
    Urology; 1991 May; 37(5):481-2. PubMed ID: 1902606
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term follow-up of cytostatic intravesical instillation in patients with superficial bladder carcinoma. Is short-term, intensive instillation better than maintenance therapy?
    Schwaibold H; Pichlmeier U; Klingenberger HJ; Huland H
    Eur Urol; 1997; 31(2):153-9. PubMed ID: 9076457
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Superficial bladder cancer: intravesical chemotherapy and tumour progression to muscle invasion or metastases.
    Smith G; Elton RA; Chisholm GD; Newsam JE; Hargreave TB
    Br J Urol; 1986 Dec; 58(6):659-63. PubMed ID: 3099881
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intravesical mitomycin C and superficial bladder tumors.
    Biserte J; Rigot JM; Mauroy B; Mazeman E
    Prog Clin Biol Res; 1989; 303():411-5. PubMed ID: 2506555
    [No Abstract]   [Full Text] [Related]  

  • 60. Value of an Immediate Intravesical Instillation of Mitomycin C in Patients with Non-muscle-invasive Bladder Cancer: A Prospective Multicentre Randomised Study in 2243 patients.
    Bosschieter J; Nieuwenhuijzen JA; van Ginkel T; Vis AN; Witte B; Newling D; Beckers GMA; van Moorselaar RJA
    Eur Urol; 2018 Feb; 73(2):226-232. PubMed ID: 28705539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.